Wells Fargo’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.76M Buy
20,669
+2,572
+14% +$741K ﹤0.01% 2477
2025
Q4
$5.48M Buy
18,097
+522
+3% +$163K ﹤0.01% 2589
2025
Q3
$4.93M Sell
17,575
-1,379
-7% -$375K ﹤0.01% 2586
2025
Q2
$4.57M Sell
18,954
-4,669
-20% -$1.1M ﹤0.01% 2549
2025
Q1
$5.75M Sell
23,623
-16,716
-41% -$5.03M ﹤0.01% 2291
2024
Q4
$13.3M Sell
40,339
-2,426
-6% -$823K ﹤0.01% 1647
2024
Q3
$14.3M Sell
42,765
-1,252
-3% -$398K ﹤0.01% 1548
2024
Q2
$12M Buy
44,017
+1,940
+5% +$564K ﹤0.01% 1585
2024
Q1
$14.6M Buy
42,077
+6,218
+17% +$2.04M ﹤0.01% 1458
2023
Q4
$11.6M Sell
35,859
-5,087
-12% -$1.59M ﹤0.01% 1583
2023
Q3
$14.7M Buy
40,946
+11,910
+41% +$4.6M ﹤0.01% 1298
2023
Q2
$11M Sell
29,036
-516
-2% -$210K ﹤0.01% 1540
2023
Q1
$14.2M Buy
29,552
+4,494
+18% +$2.1M ﹤0.01% 1341
2022
Q4
$10.5M Buy
25,058
+1,033
+4% +$417K ﹤0.01% 1511
2022
Q3
$10M Sell
24,025
-1,013
-4% -$505K ﹤0.01% 1519
2022
Q2
$12.4M Sell
25,038
-31,677
-56% -$16.5M ﹤0.01% 1426
2022
Q1
$31.9M Buy
56,715
+5,302
+10% +$3.2M 0.01% 1017
2021
Q4
$38.8M Sell
51,413
-306,737
-86% -$230M 0.01% 906
2021
Q3
$267M Buy
358,150
+12,986
+4% +$9.73M 0.06% 315
2021
Q2
$222M Sell
345,164
-5,567
-2% -$3.39M 0.05% 372
2021
Q1
$200M Buy
350,731
+10,751
+3% +$6.37M 0.05% 396
2020
Q4
$198M Sell
339,980
-74,096
-18% -$42.2M 0.05% 384
2020
Q3
$213M Sell
414,076
-114,911
-22% -$58.2M 0.06% 314
2020
Q2
$239M Buy
528,987
+20,621
+4% +$9.1M 0.07% 270
2020
Q1
$178M Sell
508,366
-11,530
-2% -$4.24M 0.06% 295
2019
Q4
$192M Sell
519,896
-151,453
-23% -$53.4M 0.05% 358
2019
Q3
$223M Buy
671,349
+69,761
+12% +$22.8M 0.06% 305
2019
Q2
$188M Sell
601,588
-28,162
-4% -$8.43M 0.05% 347
2019
Q1
$193M Sell
629,750
-16,375
-3% -$4.42M 0.06% 331
2018
Q4
$150M Sell
646,125
-41,824
-6% -$11.2M 0.05% 376
2018
Q3
$215M Sell
687,949
-30,270
-4% -$9.4M 0.06% 311
2018
Q2
$207M Buy
718,219
+43,090
+6% +$11.9M 0.06% 311
2018
Q1
$169M Buy
675,129
+50,097
+8% +$12.8M 0.05% 385
2017
Q4
$149M Buy
625,032
+89,347
+17% +$21.7M 0.04% 425
2017
Q3
$119M Buy
535,685
+11,809
+2% +$2.66M 0.04% 488
2017
Q2
$119M Buy
523,876
+252,643
+93% +$55.1M 0.04% 483
2017
Q1
$54.1M Sell
271,233
-80,165
-23% -$15.4M 0.02% 817
2016
Q4
$64.1M Sell
351,398
-194,631
-36% -$33.2M 0.02% 700
2016
Q3
$89.4M Buy
546,029
+2,870
+0.5% +$436K 0.03% 546
2016
Q2
$77.7M Sell
543,159
-25,561
-4% -$3.65M 0.03% 565
2016
Q1
$77.8M Sell
568,720
-1,189
-0.2% -$156K 0.03% 556
2015
Q4
$79M Buy
569,909
+11,050
+2% +$1.53M 0.03% 547
2015
Q3
$75.1M Sell
558,859
-59,244
-10% -$8.53M 0.03% 567
2015
Q2
$93.1M Sell
618,103
-31,588
-5% -$4.52M 0.04% 530
2015
Q1
$87.8M Sell
649,691
-54,464
-8% -$6.75M 0.03% 532
2014
Q4
$84.9M Buy
704,155
+34,408
+5% +$3.96M 0.03% 532
2014
Q3
$75.9M Sell
669,747
-90,397
-12% -$10.7M 0.03% 551
2014
Q2
$91M Sell
760,144
-1,623
-0.2% -$198K 0.04% 508
2014
Q1
$97.6M Buy
761,767
+253,834
+50% +$32.5M 0.04% 470
2013
Q4
$62.8M Buy
507,933
+83,062
+20% +$10.1M 0.03% 642
2013
Q3
$49.9M Buy
424,871
+80,975
+24% +$9.55M 0.02% 690
2013
Q2
$38.6M Buy
+343,896
New +$40.3M 0.02% 757

Other funds holding BIO